Big Bucks, Big Tech: A New Yorker’s Take on Oriental Harbor’s ETF Moves So listen up, folks. There’s buzz on Wall Street. Oriental Harbor trimmed a hefty $5.4 million from their TQQQ ETF holdings. But don’t worry, they’re still hitching a ride on the tech train. The TQQQ ETF Move Imagine this: you’re holding a […]
Therapeutic mainstays like oncology and neuroscience have hogged the spotlight lately. With flashy billion-dollar acquisitions and groundbreaking drugs for diseases like Alzheimer’s and various cancers, who could look away? Big players like Johnson & Johnson haven’t been shy, forking over a hefty sum of $14.6 billion for neuropsychiatric leader Intra-Cellular Therapies. But wait, 2025 might […]
